Related Experiment Video
Updated: Aug 6, 2026

10:00
Development of Mesenchymal Stem Cell Membrane-Enveloped Nanovesicles for Enhanced Gene Delivery
Published on: February 17, 2026
Toward Safe and Effective Gene Therapy: Non-Viral Nanostructured Delivery Systems
Fatemeh Madani1, Elaheh Izadi2, Maral Motamedi1
1Department of Medical Nanotechnology, Tehran University of Medical Sciences, Tehran, Iran.
International Journal of Nanomedicine
|July 20, 2026
Summary
Non-viral gene delivery systems offer safer alternatives to viral vectors for gene therapy. This review highlights advances in non-viral vectors, focusing on improving gene delivery efficiency for various diseases, especially cancers.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Nanotechnology
Background:
- Gene therapy holds great promise for treating genetic disorders but faces challenges with viral vectors.
- Viral vectors exhibit limitations such as immunogenicity, insertional mutagenesis, and production difficulties, hindering clinical translation.
- Non-viral gene delivery systems are emerging as safer and more adaptable alternatives.
Purpose of the Study:
- To systematically review recent advances in non-viral gene delivery vectors.
- To analyze key parameters influencing the efficiency of non-viral gene delivery.
- To evaluate the translational potential and therapeutic applications of non-viral vectors, particularly in cancer treatment.
Main Methods:
- Comprehensive literature review of non-viral vector technologies.
- Analysis of physicochemical properties influencing cellular uptake, endosomal escape, and nuclear localization.
- Evaluation of preclinical and clinical studies on non-viral gene delivery systems.
Main Results:
- Non-viral platforms like nanoparticles, polymers, and dendrimers offer customizable properties and scalable manufacturing.
- These systems demonstrate reduced immunogenicity and improved safety profiles compared to viral vectors.
- Key parameters influencing transfection efficiency have been identified, paving the way for optimized gene delivery.
Conclusions:
- Non-viral vectors are poised to overcome the limitations of viral gene delivery.
- Advances in non-viral systems offer safer, more adaptable, and clinically relevant next-generation gene therapies.
- Further research and development in non-viral vectors will accelerate the clinical translation of gene therapy for diverse diseases, including cancer.
Related Concept Videos
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
